Catherine Singfield
Senior Director, Head of EUR/INT Medical, Evidence Optimisation & Managed Access Programmes Team Jazz Pharmaceuticals plc
Catherine Singfield leads Evidence Optimisation and Managed Access Programmes across Europe and International markets at Jazz Pharmaceuticals. She focuses on shaping how clinical, real-world, and access-driven evidence is generated and leveraged to support early and sustained patient access. Catherine brings extensive experience across medical affairs operations, launch planning, and cross-regional strategy, working closely with medical, commercial, and access teams to ensure programmes are evidence-led, scalable, and aligned with evolving healthcare expectations.
Seminars
Wednesday 21st October 2026
ia4ma: Achieving Global Impact Through a Non-Profit, Independent Association
1:45 pm
- Establishing a shared vision and foundation for Managed Access, aligning on ethical principles and industry standards to reduce fragmentation and enable sustainable global pathways
- Delivering value for patients, industry and stakeholders by accelerating equitable access, improving operational efficiency, and enabling meaningful peer and regulatory exchange
- Driving system level impact beyond individual programs by shaping policy, fostering multi stakeholder collaboration, and strengthening global trust in Managed Access
